ArticleBasic research in cardiology2017
Repeated doses of cardiac mesenchymal cells are therapeutically superior to a single dose in mice with old myocardial infarction.
Open access · greenAbstract read
In one paragraph
Article in Basic research in cardiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.
0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
8.8field-weighted citation impact, top 2% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
61 citing papers in PubMed, 85 citations in OpenAlex.
- Allogeneic Human Umbilical Cord Mesenchymal Stem Cells for the Treatment of Autism Spectrum Disorder in Children: Safety Profile and Effect on Cytokine Levels.Stem cells translational medicine · 2019Trial
- Click chemistry-modified cardiomyocytes enhance cardiac contractility and prevent remodeling in ischemia-reperfusion injured hearts.Bioactive materials · 2027Article
- Comparative Effects of Repeated Intravenous Infusions of Progenitor Cells in a Rat Model of Chronic Ischemic Cardiomyopathy.Stem cell reviews and reports · 2026Article
- Administration of Single or Repeated Doses of CDCs in a Swine Model of Reperfused Myocardial Infarction: Magnetic Resonance and Proteomics Evaluation.International journal of molecular sciences · 2025Article
- Intravenous infusions of mesenchymal stromal cells have cumulative beneficial effects in a porcine model of chronic ischaemic cardiomyopathy.Cardiovascular research · 2024Article
- Regenerative loss in the animal kingdom as viewed from the mouse digit tip and heart.Developmental biology · 2024Review
- Autologous bone marrow-derived nucleated cell (aBMNC) transplantation improves endometrial function in patients with refractory Asherman's syndrome or with thin and dysfunctional endometrium.Journal of assisted reproduction and genetics · 2023Article
- PU.1 inhibition does not attenuate cardiac function deterioration or fibrosis in a murine model of myocardial infarction.Molecular and cellular biochemistry · 2023Article
- ZipperCells Exhibit Enhanced Accumulation and Retention at the Site of Myocardial Infarction.Advanced healthcare materials · 2023Article
- Intravenously transplanted mesenchymal stromal cells: a new endocrine reservoir for cardioprotection.Stem cell research & therapy · 2022Article
- Cardiac Cell Therapy with Pluripotent Stem Cell-Derived Cardiomyocytes: What Has Been Done and What Remains to Do?Current cardiology reports · 2022Review
- State of the field: cellular and exosomal therapeutic approaches in vascular regeneration.American journal of physiology. Heart and circulatory physiology · 2022Review
- Cell therapy in patients with heart failure: a comprehensive review and emerging concepts.Cardiovascular research · 2022Review
- Irisin Promotes Cardiac Homing of Intravenously Delivered MSCs and Protects against Ischemic Heart Injury.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022Article
- Effect of intravenous cell therapy in rats with old myocardial infarction.Molecular and cellular biochemistry · 2022Article
- The sad plight of cell therapy for heart failure: causes and consequences.The journal of cardiovascular aging · 2022Article
- Clinical mesenchymal stem cell therapy in ischemic cardiomyopathy.JTCVS open · 2021Article
- Single dose of synthetic microRNA-199a or microRNA-149 mimic does not improve cardiac function in a murine model of myocardial infarction.Molecular and cellular biochemistry · 2021Article
- Physiological Oxygen Tension Enhances Competence and Functional Properties of Murine Cardiac Mesenchymal Cells.Stem cell reviews and reports · 2021Article
- Echocardiography-guided percutaneous left ventricular intracavitary injection as a cell delivery approach in infarcted mice.Molecular and cellular biochemistry · 2021Article
1 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors at 1 institution in 1 country.
Yiru GuoInstitute of Molecular Cardiology, University of Louisville School of Medicine, Louisville, KY, USA.ORCID http://orcid.org/0000-0002-0614-9899
Marcin WysoczynskiInstitute of Molecular Cardiology, University of Louisville School of Medicine, Louisville, KY, USA.
Yibing NongInstitute of Molecular Cardiology, University of Louisville School of Medicine, Louisville, KY, USA.
Alex TomlinInstitute of Molecular Cardiology, University of Louisville School of Medicine, Louisville, KY, USA.
Xiaoping ZhuInstitute of Molecular Cardiology, University of Louisville School of Medicine, Louisville, KY, USA.
Anna M GumpertInstitute of Molecular Cardiology, University of Louisville School of Medicine, Louisville, KY, USA.
Marjan NasrInstitute of Molecular Cardiology, University of Louisville School of Medicine, Louisville, KY, USA.
Senthikumar MuthusamyInstitute of Molecular Cardiology, University of Louisville School of Medicine, Louisville, KY, USA.
Hong LiInstitute of Molecular Cardiology, University of Louisville School of Medicine, Louisville, KY, USA.
Michael BookInstitute of Molecular Cardiology, University of Louisville School of Medicine, Louisville, KY, USA.
Abdur KhanInstitute of Molecular Cardiology, University of Louisville School of Medicine, Louisville, KY, USA.
Kyung U HongInstitute of Molecular Cardiology, University of Louisville School of Medicine, Louisville, KY, USA.
Qianhong LiInstitute of Molecular Cardiology, University of Louisville School of Medicine, Louisville, KY, USA.
Roberto BolliInstitute of Molecular Cardiology, University of Louisville School of Medicine, Louisville, KY, USA. rbolli@louisville.edu.
University of Louisville · US
Funding
Tumor Necrosis Factor Modulation of CPCsP01HL078825 · NHLBI · UNIVERSITY OF LOUISVILLE · PI BOLLI, ROBERTO · 2005 to 2021
$37.6MProject 5 - Metabolomic Analysis of AtherothrombosisP20GM103492 · NIGMS · UNIVERSITY OF LOUISVILLE · PI DEFILIPPIS, ANDREW · 2012 to 2017
$13.8MSTEM CELLS AND DIABETIC CARDIOMYOPATHY PROJ 2 2009P20RR024489 · NCRR · UNIVERSITY OF LOUISVILLE · PI BHATNAGAR, ARUNI · 2008 to 2011
$10.0MUniversity of Louisville Regional Clinical Center for the CCTRNUM1HL113530 · NHLBI · UNIVERSITY OF LOUISVILLE · PI BOLLI, ROBERTO · 2012 to 2018
$2.9MNCRR NIH HHS P20 RR024489NHLBI NIH HHS P01 HL078825NHLBI NIH HHS UM1 HL113530NIGMS NIH HHS P20 GM103492
Abstract
We have recently demonstrated that repeated administrations of c-kit
Indexed as
Myocardial InfarctionAnimalsDisease Models, AnimalEchocardiographyFemaleImmunohistochemistryMaleMesenchymal Stem CellsMesenchymal Stem Cell TransplantationMiceMice, Inbred C57BLMyocytes, CardiacRandom AllocationCell therapyIschemic cardiomyopathyProgenitor cellsStem cells
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.